The Flagellin-TLR5 Axis: Therapeutic Opportunities

Area of Science:

• Microbiology
• Immunology
• Molecular Biology

Background:

• Flagella are large bacterial surface structures built from flagellin protein subunits.
• Flagellin sequences show conserved amino and carboxy termini but divergent central regions.
• Monomeric flagellin has roles beyond bacterial adhesion, acting as an immunostimulatory factor.

Purpose of the Study:

• To investigate the immunostimulatory and proinflammatory roles of monomeric flagellin.
• To elucidate the mechanism of flagellin-mediated immune activation via Toll-like receptor 5 (TLR5).
• To explore the therapeutic potential of targeting the flagellin-TLR5 pathway.

Main Methods:

• Analysis of flagellin amino acid sequences across different Gram-negative species.
• In vitro studies assessing the response of monocytes, macrophages, and epithelial cells to monomeric flagellin.
• In vivo administration of flagellin to evaluate immune and inflammatory responses.

Main Results:

• Monomeric flagellin activates the immune system via the Toll-like receptor 5-nuclear factor-kappaB (TLR5-NF-κB) pathway.
• Low concentrations of flagellin elicit significant immune and inflammatory responses in various cell types.
• Flagellin administration induces local and systemic responses comparable to bacterial lipopolysaccharide.

Conclusions:

• Monomeric flagellin is a potent immunostimulatory and proinflammatory molecule.
• The flagellin-TLR5 pathway is a key mediator of bacterial-induced inflammation.
• Targeting flagellin-TLR5 interactions presents novel therapeutic strategies for shock, sepsis, and ARDS.